Testosterone causes the tissue of the front hole to become thinner, drier and less elastic over time. That is a normal and expected effect of treatment, and it has a practical consequence for sexual health that is worth understanding rather than worrying about.
What actually changes?
The lining thins, natural lubrication reduces substantially, and the tissue becomes more fragile. Clinically this is called atrophy, which sounds more alarming than it is. It develops gradually over months to years on testosterone and affects people to differing degrees.
Why does that matter for infection?
Because tissue that tears more easily provides more points of entry. Microscopic tears during sex increase susceptibility to HIV and to bacterial infections, for the same reason they do at any other site. The effect is real and it is not dramatic; it shifts the picture rather than transforming it.
What helps?
Plenty of lubricant, reapplied rather than used once at the start, and a low osmolality product that does not draw water out of the tissue. This alone resolves a great deal of the discomfort and most of the tearing. Going slower and stopping when something hurts matter more than they would otherwise.
What about topical oestrogen?
A cream or pessary applied locally is frequently prescribed for exactly this and works well. The amount absorbed into the bloodstream is very small and does not meaningfully affect masculinising treatment, which is the concern most people have. It is worth asking about at a gender service, a sexual health clinic or a GP, and a great many people are never offered it.
Does it affect examinations and swabs?
It can make them uncomfortable, which is a reason to ask for a self-taken swab, a smaller speculum, or topical oestrogen for a period beforehand where an examination is unavoidable. This applies particularly to cervical screening, which people frequently avoid for this reason.
Does testosterone change anything else?
Growth of the clitoris, changes in sensation and libido, and changes to how sex feels generally. None of these affect infection risk. Testosterone also does not prevent pregnancy, which is a separate and important point that people are frequently misinformed about.
Should you stop testosterone?
No. This is a manageable side effect with a direct treatment, and it is not a reason to interrupt hormone therapy. Anyone suggesting otherwise is proposing a considerably larger intervention than the problem warrants.
What should you do about prevention?
PrEP taken daily, with a seven-day lead-in before frontal sex, since the shortcut schedule does not apply to this site. Condoms where you want them, with plenty of lubricant, since a dry condom on fragile tissue causes more friction rather than less. Vaccinations completed.
What is worth mentioning at a clinic?
Dryness, discomfort during sex, bleeding afterwards, or repeated infections. All are treatable and all are common enough that staff will not be surprised. Bleeding that is new, persistent or heavy warrants being looked at rather than attributed to atrophy.
What about testing?
Swab the front hole if you use it for sex, alongside throat and rectum as relevant. Say which sites you use rather than leaving it to be assumed, since this is the site most often missed.
Does it change over time?
The tissue effects develop gradually over the first years and then stabilise for most people. Someone three months into testosterone is in a different position from someone five years in, which is worth mentioning at a clinic rather than leaving to be assumed.
Does it affect anything about the other sites?
No. Throat and rectal tissue are unaffected by testosterone, so nothing changes about screening or prevention at those sites. This is specifically about frontal tissue.